Member Info for JOHNO77

Isn’t the presentation meant to come out tomorrow?

Not sure what new material could be in it…. We already had presentations for both the Nanaogenics and SRI deals…! Nothing major of note has happened since!?!? (apart from the placing of course!!)

'coz his holding was 24,600,000 prior to placing and 33,000,000 afterwards. Scroll down to bottom of rns which also confirms he took part.

Looks like Mr Kay added 8.4 mill, £42k's worth, in placing

Https://issuu.com/shares-magazine/docs/spotlight_30_may_2024#:~:text=Biotech%20firm%20N4%20Pharma%20is,oncology%2C%20gene%20therapy%20and%20vaccines.

Positive update today

Very nice update :)

Being well bid again...nice

Dowgate Wealth have been buying throughout and the needle hasn't budged. Maybe disposed of some property?

Now back concentrating on their core services that actually make money, RBG's in a much better place.

??

Oops, Nanomerics, not Nanogenics!

Great news for Nanomerics and further validates their credentials

Yes it looks like an exciting new venture. Hopefully the presentation clarifies more on the funding and timeline for lab work. The 'ventures' page of the SRI website implies that SRI provide lab funding in exchange for modest equity on any successful product. If that's the case it sounds like a good deal to me. SRI obviously think that Nuvec has potential to optimise their own MGS product.

You would assume that SRI are not going to waste their time partnering with a company / product unless it has a certain degree of potential for commercial success. SRI clearly like what they see with Nuvec.

It is currently difficult for N4 to showcase their product to 'big pharma' so this collaboration should make it much easier to do so.

Sounds like a great step forward for N4P.

This is exactly the reassurance investors needed.

Well done to the company, this is much better news.

Yes a few little wins and encouraging news of late. We have seen n4p, n3p, n2p,. n1p and now even n0.6p so hopefully the train will at some point move in the opposite direction.

GLA.

All these 'positive findings' but as of yet zero commercial traction. It's time to deliver for N4P.

Maybe a Robin reliant at this rate…?

The deadline is 30th June. They will be later than the last couple of years but not ' late late' unless after 30.06.24.

Yep, zero debt, strong cashflow, yoy growth, love this one.

Time to start revving the Punto.... Don't forget to use the choke...!